Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TYKERB for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where TYKERB was used for Neoplasm malignant.

Most Reported Side Effects for TYKERB

Side Effect Reports % Deaths Hosp.
Diarrhoea 173 32.5% 3 12
Nausea 63 11.8% 7 10
Death 47 8.8% 47 1
Fatigue 44 8.3% 3 5
Drug ineffective 42 7.9% 1 4
Rash 37 6.9% 0 2
Disease progression 29 5.4% 10 3
Vomiting 29 5.4% 2 7
Decreased appetite 28 5.3% 3 2
Palmar-plantar erythrodysaesthesia syndrome 23 4.3% 0 3
Weight decreased 23 4.3% 2 4
Dizziness 22 4.1% 4 8
Dry skin 22 4.1% 0 1
Stomatitis 19 3.6% 1 2
Malaise 18 3.4% 0 0

Other Indications for TYKERB

Breast cancer (282) Product used for unknown indication (133) Breast cancer metastatic (54) Breast cancer female (12)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

TYKERB Full Profile All Neoplasm malignant Drugs TYKERB Demographics TYKERB Timeline